Literature DB >> 345781

The role of macrophage activation in chronic inflammation.

A C Allison, J Ferluga, H Prydz, H U Schorlemmer.   

Abstract

The macrophage is the characteristic cell type in chronic inflammatory reactions, in the rheumatoid synovium, as in other sites. When macrophages are activated, considerable synthesis of enzymes and other proteins occurs. Macrophages can be activated by (i) products of activated lymphocytes, (ii) immune complexes and (iii) the complement cleavage product C3b. Among the many consequences of macrophage activation are (i) secretion of hydrolytic enzymes, (ii) cleavage of C3 into C3a, which is cytolytic, and C3b, (iii) production of tissue thromboplastin, a powerful procoagulant, and (iv) formation of polyamine oxidase, which in the presence of appropriate substrates generates factors that lyse or limit the proliferation of tumour cells, lymphocytes and micro-organisms. The relevance of these observations to the pathogenesis of chronic inflammatory reactions is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 345781     DOI: 10.1007/bf01972398

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  29 in total

1.  Collagenase production by lymphokine-activated macrophages.

Authors:  L M Wahl; S M Wahl; S E Mergenhagen; G R Martin
Journal:  Science       Date:  1975-01-24       Impact factor: 47.728

2.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Release of colony-stimulating factor from monocytes by endotoxin and polyinosinic-polycytidylic acid.

Authors:  F W Ruscetti; P A Chervenick
Journal:  J Lab Clin Med       Date:  1974-01

4.  Immune complexes induce selective release of lysosomal hydrolases from macrophages.

Authors:  C J Cardella; P Davies; A C Allison
Journal:  Nature       Date:  1974-01-04       Impact factor: 49.962

5.  The protein component of human brain thromboplastin.

Authors:  E Bjorklid; E Storm; H Prydz
Journal:  Biochem Biophys Res Commun       Date:  1973-12-10       Impact factor: 3.575

6.  In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.

Authors:  C Bentley; D Bitter-Suermann; U Hadding; V Brade
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

7.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1975-01       Impact factor: 4.307

Review 8.  Biosynthesis and metabolism of 1,4-diaminobutane, spermidine, spermine, and related amines.

Authors:  H Tabor; C W Tabor
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1972

9.  Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

10.  A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro.

Authors:  S J Leibovich; R Ross
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

View more
  18 in total

Review 1.  The role of the macrophage in collagen resorption during chronic inflammation. A new look at an old hypothesis.

Authors:  D A Deporter
Journal:  Agents Actions       Date:  1979-06

Review 2.  [Importance of fibroblast chemotaxis in wound healing and tumor cell evasion].

Authors:  H Mensing
Journal:  Klin Wochenschr       Date:  1985-02-15

3.  The chemiluminescent response of human phagocytic cells to mineral dusts.

Authors:  I P Gormley; M J Kowolik; R T Cullen
Journal:  Br J Exp Pathol       Date:  1985-08

4.  alpha 2-Macroglobulin as an inclusion in synovial fluid monocytes.

Authors:  E Flory; T L Vischer
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

5.  Chemiluminescence of asbestos-activated macrophages.

Authors:  K Donaldson; R T Cullen
Journal:  Br J Exp Pathol       Date:  1984-02

6.  Concanavalin A receptors and capping in control and activated macrophages.

Authors:  K Donaldson; J M Davis; K James
Journal:  Histochem J       Date:  1983-01

7.  Investigations on vitamin E and lipid peroxide status in rheumatic diseases.

Authors:  M Mezes; G Bartosiewicz
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

8.  Formation of histamine-releasing activity from albumin by medium conditioned by endotoxin-stimulated rat peritoneal macrophages.

Authors:  D E Cochrane; W Boucher; R E Carraway
Journal:  Agents Actions       Date:  1992-01

9.  Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model.

Authors:  Ho Won Lee; Yong Hyun Jeon; Mi-Hye Hwang; Jung-Eun Kim; Tae-in Park; Jeoung-Hee Ha; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

10.  Activation of jird (Meriones unguiculatus) macrophages by the filarial parasite Brugia pahangi.

Authors:  G W Jeffers; T R Klei; F M Enright
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.